Estimating the Economic Impact of Sorafenib in Treatment of Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma (DTC) That is Refractory to Radioactive Iodine (RAI) Treatment
Abstract
Authors
M. Sussman M. Munsell A. Valderrama B.S. Seal L. Wen